Zahi Mitri

Assistant Professor

  • 108 Citations
  • 7 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 108 Citations
  • 7 h-Index
  • 7 Article
  • 1 Chapter
  • 1 Review article

Cytochrome P4502E1 (CYP2E1) genetic polymorphisms in a lebanese population: Frequency distribution and association with morbid diseases

Zgheib, N. K., Mitri, Z., Geryess, E. & Noutsi, P., Jun 1 2010, In : Genetic Testing and Molecular Biomarkers. 14, 3, p. 393-397 5 p.

Research output: Contribution to journalArticle

8 Scopus citations

Pharmacogenetics and personalized medicine: The future for drug prescribing

Mitri, Z., Esmerian, M. O., Simaan, J. A., Sabra, R. & Zgheib, N. K., Apr 1 2010, In : Journal Medical Libanais. 58, 2, p. 101-104 4 p.

Research output: Contribution to journalReview article

8 Scopus citations

Influence of CYP2C9 and VKORC1 polymorphisms on warfarin and acenocoumarol in a sample of lebanese people

Esmerian, M. O., Mitri, Z., Habbal, M. Z., Geryess, E., Zaatari, G., Alam, S., Skouri, H. N., Mahfouz, R. A., Taher, A. & Zgheib, N. K., Oct 1 2011, In : Journal of Clinical Pharmacology. 51, 10, p. 1418-1428 11 p.

Research output: Contribution to journalArticle

24 Scopus citations

Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphoma

Mitri, Z., Siddiqui, M. T., El Rassi, F., Holden, J. T., Heffner, L. T., Langston, A., Waller, E. K., Winton, E., McLemore, M., Bernal-Mizrachi, L., Jaye, D., Arellano, M. & Khoury, H. J., Jul 2014, In : Leukemia and Lymphoma. 55, 7, p. 1498-1500 3 p.

Research output: Contribution to journalArticle

9 Scopus citations

A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancer

Mitri, Z., Karakas, C., Wei, C., Briones, B., Simmons, H., Ibrahim, N., Alvarez, R., Murray, J. L., Keyomarsi, K. & Moulder, S., Aug 2015, In : Investigational New Drugs. 33, 4, p. 890-894 5 p.

Research output: Contribution to journalArticle

31 Scopus citations

BRCAPRO 6.0 model validation in male patients presenting for BRCA testing

Mitri, Z. I., Jackson, M., Garby, C., Song, J., Giordano, S. H., Hortobágyi, G. N., Singletary, C. N., Hashmi, S. S., Arun, B. K. & Litton, J. K., 2015, In : Oncologist. 20, 6, p. 593-597 5 p.

Research output: Contribution to journalArticle

6 Scopus citations

TBCRC-010: Phase I/II study of dasatinib in combination with zoledronic acid for the treatment of breast cancer bone metastasis

Mitri, Z., Nanda, R., Blackwell, K., Costelloe, C. M., Hood, I., Wei, C., Brewster, A. M., Ibrahim, N. K., Koenig, K. B., Hortobagyi, G. N., Van Poznak, C., Rimawi, M. F. & Moulder-Thompson, S., Dec 1 2016, In : Clinical Cancer Research. 22, 23, p. 5706-5712 7 p.

Research output: Contribution to journalArticle

15 Scopus citations
7 Scopus citations

Using Reverse Phase Protein Array (RPPA) to Identify and Target Adaptive Resistance

Labrie, M., Fang, Y., Kendsersky, N. D., Li, J., Liang, H., Westin, S. N., Mitri, Z. & Mills, G. B., 2019, Advances in Experimental Medicine and Biology. Springer, p. 251-266 16 p. (Advances in Experimental Medicine and Biology; vol. 1188).

Research output: Chapter in Book/Report/Conference proceedingChapter